info@rightsightresearch.com Asia Pacific pharmaceutical contract research organization (CRO) market will grow by 11.3% annually with a total addressable market cap of $ 212.8 billion over 2022-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.Highlighted with 66 tables and 47 figures, this 139-page … Read more
Global digital PCR (dPCR) market will reach $ 1,169.9 million by 2031, growing by 11.8% annually over 2021-2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities.Highlighted with 83 tables and 77 figures, … Read more
North America digital PCR (dPCR) market is projected to grow by 10.1% annually in the forecast period and reach $ 451.6 million by 2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities.Highlighted … Read more
Europe digital PCR (dPCR) market was valued at $116.4 million in 2021 and will grow by 11.5% annually over 2021-2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities.Highlighted with 32 tables and … Read more
Asia Pacific digital PCR (dPCR) market will grow by 15.2% annually with a total addressable market cap of $1,699.2 million over 2022-2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities.Highlighted with 29 … Read more
Global bioanalytical testing services market will reach $7,902.9 million by 2031, growing by 9.1% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by … Read more
North America bioanalytical testing services market is projected to grow by 8.3% annually in the forecast period and reach $ 3,232.3 million by 2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and … Read more
Global electronic design automation (EDA) tools market will reach $ 28,812.7 million by 2031, growing by 9.6% annually over 2021-2031, driven by the strong performance of the semiconductor industry, emergence of advanced chip architectures and other novel technologies such as AI/VR/IoT, and the rapid development of system-on-a-chip (SoC) technology coupled with the emerging trend of … Read more
Asia Pacific bioanalytical testing services market will grow by 11.2% annually with a total addressable market cap of $ 13,359.1 million over 2022-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the … Read more
Global clinical trials market will reach $ 79,977.1 million by 2031, growing by 6.8% annually over 2021-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase … Read more